NCT07415031
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07415031
Title A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ROU | ESP | DEU | CAN


No variant requirements are available.